187 related articles for article (PubMed ID: 10076797)
21. [Analysis of dissemination pathways for poliovirus].
Ohka S
Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
[TBL] [Abstract][Full Text] [Related]
22. In vitro interaction of poliovirus with cytoplasmic dynein.
González Durán E; del Angel RM; Salas Benito JS
Intervirology; 2007; 50(3):214-8. PubMed ID: 17283448
[TBL] [Abstract][Full Text] [Related]
23. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
[TBL] [Abstract][Full Text] [Related]
25. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
Cello J; Paul AV; Wimmer E
Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
[TBL] [Abstract][Full Text] [Related]
26. [Neurotropism of poliovirus].
Koike S
Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1231-6. PubMed ID: 17824245
[No Abstract] [Full Text] [Related]
27. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase.
Pelletier I; Duncan G; Pavio N; Colbère-Garapin F
Cell Mol Life Sci; 1998 Dec; 54(12):1385-402. PubMed ID: 9893712
[TBL] [Abstract][Full Text] [Related]
29. Early events in poliovirus infection: virus-receptor interactions.
Racaniello VR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11378-81. PubMed ID: 8876143
[TBL] [Abstract][Full Text] [Related]
30. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
Whelan SP; Evans D; Almond JW
Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
[No Abstract] [Full Text] [Related]
31. Recent insights into poliovirus pathogenesis.
Ohka S; Nomoto A
Trends Microbiol; 2001 Oct; 9(10):501-6. PubMed ID: 11597452
[TBL] [Abstract][Full Text] [Related]
32. Some problems of molecular biology of poliovirus infection relevant to pathogenesis, viral spread and evolution.
Agol VI; Belov GA; Cherkasova EA; Gavrilin GV; Kolesnikova MS; Romanova LI; Tolskaya EA
Dev Biol (Basel); 2001; 105():43-50. PubMed ID: 11763336
[TBL] [Abstract][Full Text] [Related]
33. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
34. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.
Ohka S; Matsuda N; Tohyama K; Oda T; Morikawa M; Kuge S; Nomoto A
J Virol; 2004 Jul; 78(13):7186-98. PubMed ID: 15194795
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.
Ohka S; Igarashi H; Nagata N; Sakai M; Koike S; Nochi T; Kiyono H; Nomoto A
J Virol; 2007 Aug; 81(15):7902-12. PubMed ID: 17507470
[TBL] [Abstract][Full Text] [Related]
36. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
Racaniello VR
Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
[TBL] [Abstract][Full Text] [Related]
37. Poliovirus neurovirulence and attenuation, a conceptual framework.
John TJ
Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
[No Abstract] [Full Text] [Related]
38. [Molecular mechanism of tissue-specific infection of poliovirus].
Koike S
Uirusu; 2004 Dec; 54(2):205-12. PubMed ID: 15745158
[TBL] [Abstract][Full Text] [Related]
39. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
40. [Poliovirus infection in the transgenic mouse model].
Koike S
Jikken Dobutsu; 1993 Jul; 42(3):296-9. PubMed ID: 8394822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
